Dow Up 0.15% Nasdaq Up 0.21%

Repligen Corporation (RGEN)

-NasdaqGS
19.57 0.37(1.93%) Sep 17, 4:00PM EDT
Prev Close:19.20
Open:19.09
Bid:7.66 x 100
Ask:N/A
1y Target Est:24.33
Beta:1.49
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:19.06 - 19.68
52wk Range:9.84 - 24.68
Volume:279,611
Avg Vol (3m):405,831
Market Cap:638.92M
P/E (ttm):35.01
EPS (ttm):0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RGEN

Comparison

Symbol% ChgMkt Cap
RGENUp 1.93%638.92M
BIO3.41B

Key Statistics

Forward P/E (1 yr):54.36
P/S (ttm):9.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.28
Quarterly EPS Est (Sep-14) :0.04
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback